The Spanish Agency for Medicines and Health Products (AEMPS).
The Spanish Agency for Medicines and Health Products (AEMPS) issued a A healthy alert Confirming the relationship between a known drug for treatment Alopecia Risk Suicide thought Of these patients.
This warning comes after a comprehensive Analysis of the risk evaluation committee in the pharmaceutical risk (PRAC) From the European Pharmaceutical Agency (EMA), which with new evidence has strengthened this negative effect already included in the technical pharmaceutical file.
AEMPS reported that they were notified Suicide thinking cases in patients treated orallyMainly in those who receive a treatment for male male trim. “The frequency of this negative effect is unknown, because it cannot be appreciated by the available data,” they say.
Currently, product information (technical and exploration paper) for these drugs It already includes warnings about mood changesLike suicide thinking, recommending to boycott treatment and go to the doctor if these symptoms appear.
During the review, cases that were notified in the European database were analyzed about doubts about negative interactions, and determining them A total of 325 cases of suicide thinking: 313 associated with Vinastraide and 13 to Duteida.
Sexual defect
The agency stated that, most of the cases associated with Vinastraide occurred in Patients treated by androgen alopeciaWhile in patients treated by benign prostate enlargement, a number of lower cases were notified ten times.
They were also notified Sexual defects In patients with precisely treated, which can contribute to the development of mood changes, including suicide thinking. PRAC reviews that the level of evidence on risk varies according to the indicators, active ingredients and evaluated compositions.
As an additional measure, Apems indicates that a Patient information card In all Finrity 1 mg containers to report the risks of mood adjustments and sexual imbalance, indicating how to behave in each case.
On DusterdaThe available data does not allow the confirmation of the causal relationship with suicide thinking; However, due to a similar work mechanism, it is a potentially classy impact on 5-ALFA Reducing inhibitors.
The information published in the medical writing contains data, data and data from official institutions and health professionals. However, given any questions related to your health, consult the opposite health specialist.
